Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yungchang Chen"'
Autor:
Limei Zhang, He Huang, Zhao Wang, Xiaojie Fang, Huangming Hong, Yungchang Chen, Quanguang Ren, Yuyi Yao, Zegeng Chen, Fei Pan, Xiaoqian Li, Meiting Chen, Tongyu Lin
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6924-6934 (2023)
Abstract Background Stomach hemorrhage and perforation are very severe and common complications in patients with primary gastric diffuse large B‐cell lymphoma (PG‐DLBCL) during treatment with immunochemotherapy. However, no relevant clinical stud
Externí odkaz:
https://doaj.org/article/fe6b38ff661b4e339c71b5f8502e671e
Autor:
Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-6 (2023)
Abstract BRAF mutations are the oncogenic drivers in colorectal cancer and V600 mutations (Class1), which lead to RAS-independent active monomers, are the most common mutation types. BRAF non-V600 mutants can be further classified as RAS-independent
Externí odkaz:
https://doaj.org/article/b5c38b1247d04bf8a6ea1dba18368eb0
Autor:
Xiaoqian Li, Huangming Hong, He Huang, Liqun Zou, Zegeng Chen, Zhihui Zhang, Liling Zhang, Xiaojie Fang, Hongqiang Guo, Ke Xie, Ying Tian, Suxia Lin, Yungchang Chen, Wei Zhang, Yuyi Yao, Fei Pan, Huawei Weng, Tongyu Lin
Publikováno v:
Cancer Medicine, Vol 11, Iss 18, Pp 3407-3416 (2022)
Abstract Background The aim of this study was to explore predictors and construct a nomogram for risk stratification in primary extragastric mucosa‐associated lymphoid tissue (MALT) lymphoma. Methods Extragastric MALT lymphoma cases newly diagnosed
Externí odkaz:
https://doaj.org/article/4948c30cc69748c5b2f18794203fc748
Autor:
Meiting Chen, Yungchang Chen, Xiaojie Fang, Zhao Wang, Xingxiang Pu, Chaoyong Liang, Hongqiang Guo, Qian Li, Fei Pan, Huangming Hong, He Huang, Jiman Li, Tongyu Lin
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resembles undifferentiated nasopharyngeal carcinoma (NPC). The population-based analysis of LELC and the optimal treatment remains
Externí odkaz:
https://doaj.org/article/aa0fcaf51a9849a8bd2e7946ebd05797
Autor:
Jun Hou, Peng Guo, Yujiao Lu, Xiaokang Jin, Ke Liang, Na Zhao, Shunxu Xue, Chengmin Zhou, Guoqiang Wang, Xin Zhu, Huangming Hong, Yungchang Chen, Huafei Lu, Wenxian Wang, Chunwei Xu, Yusheng Han, Shangli Cai, Yang Liu
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
The outcomes of patients with diffuse large B-cell lymphoma (DLBCL) vary widely, and about 40% of them could not be cured by the standard first-line treatment, R-CHOP, which could be due to the high heterogeneity of DLBCL. Here, we aim to construct a
Externí odkaz:
https://doaj.org/article/db75518968e045de85b75ba25450df96
Autor:
Xingxiang Pu, Ran Zhang, Li Wang, Yungchang Chen, Yi Xu, Apar Pataer, Ismail M. Meraz, Xiaoshan Zhang, Shuhong Wu, Lin Wu, Dan Su, Weimin Mao, John V. Heymach, Jack A. Roth, Stephen G. Swisher, Bingliang Fang
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background Because patient-derived xenografts (PDXs) are grown in immunodeficient mouse strains, PDXs are regarded as lacking an immune microenvironment. However, whether patients’ immune cells co-exist in PDXs remains uncharacterized. Met
Externí odkaz:
https://doaj.org/article/6894e6771c634171aa7604d1ac710e1d
Autor:
YungChang Chen, 陳永昌
87
Lamotrigine, 3,5-diamino-6-(2,3,dichlorophenyl-1,2,4-triazine), is a new antiepileptic drug. It is structurally unrelated to the major antiepileptic agents in current use, and is believed to exert its antiepileptic effect by inhibiting the re
Lamotrigine, 3,5-diamino-6-(2,3,dichlorophenyl-1,2,4-triazine), is a new antiepileptic drug. It is structurally unrelated to the major antiepileptic agents in current use, and is believed to exert its antiepileptic effect by inhibiting the re
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/68250039933161428220
Autor:
Limei Zhang, He Huang, Zhao Wang, Xiaojie Fang, Huangming Hong, Yungchang Chen, Quanguang Ren, Yuyi Yao, Zegeng Chen, Fei Pan, Xiaoqian Li, Meiting Chen, Tongyu Lin
Publikováno v:
Cancer medicineREFERENCES.
Stomach hemorrhage and perforation are very severe and common complications in patients with primary gastric diffuse large B-cell lymphoma (PG-DLBCL) during treatment with immunochemotherapy. However, no relevant clinical studies have been performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64302a16687ecacc28d9493463f421e
https://pubmed.ncbi.nlm.nih.gov/36621835
https://pubmed.ncbi.nlm.nih.gov/36621835
Autor:
Yungchang Chen, Xiaoqian Li, Man Yuxin, Hai Hu, Liyang Wang, Zhixuan Zhang, Ping Chen, Yang Liu, Jin Lu, Tongyu Lin
Publikováno v:
Journal of Clinical Oncology. 41:156-156
156 Background: The low efficacy of single-agent BRAF inhibitor in metastatic colorectal cancer (mCRC) is usually due to EGFR feedback upregulation caused by BRAF blockade. Therefore, multi-drug combination therapy with BRAF inhibitor has been tried.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507f35be23a63f57a621310aa3d1396a
https://doi.org/10.1200/jco.2023.41.4_suppl.156
https://doi.org/10.1200/jco.2023.41.4_suppl.156
Autor:
Yungchang Chen, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Hongqiang Guo, Mengmeng Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Xue Wu, Yang Shao, Tongyu Lin
Publikováno v:
Journal of Clinical Oncology. 40:3533-3533
3533 Background: Mutations occurring at the V600 amino acid of BRAF is the most common BRAF mutations in colorectal cancer (CRC), which lead to RAS-independent active monomers (Class 1) and are the targets of BRAF inhibitors. BRAF non-V600 mutants ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f0f25aa369b187be4919027b55d72f9
https://doi.org/10.1200/jco.2022.40.16_suppl.3533
https://doi.org/10.1200/jco.2022.40.16_suppl.3533